Literature DB >> 21432463

The effect on the bones of condensed phosphate when used as food additives: Its Importance in Relation to Preventive Medicine.

M Omoto1, T Imai, K Seki, R Nomura, Y Otahara.   

Abstract

Based on the fact that chemical products such as binding agents are produced by mixing three kinds of phosphates with different ratios, we mixed metaphosphate, polyphosphate and pyrophosphate. Each was made to Na-phosphate, K-phosphate, and Ca-phosphate and each was mixed with commercial feeds so that the content of P would be approximately 0.1, 0.15, 0.3, 0.4, 0.6 and 1.0%. The prepared pellets were given to ICR, CF # 1 and AKR strains of mice at 29 days of age for 680 days and observations were made through this experimental period at different stages. The observations were also carried out on the mice administered with the experimental feeds for 1.5 months from 9 to 10.5 months of age. The observations were compared with those of the control group at all times. As a result, plasma 1 α, 25 (OH)(2) D(3) and P levels were always significantly higher in the phosphate administered groups relative to the control. Urine P and Fe increased while urine Ca decreased in the phosphate-treated groups.The effect of phosphates on the bones was studied taking soft X-ray pictures of hind legs and applying microdensitometry to them. Through these observations we recognized thinning of the cortex of bones, reduction of marrow trabecules and development of osteophyte. Histological observations disclosed that changes in knee joint tissues were apparent; that is, a decrease in or an irregular loss of the number of cells in superficial, intermediate, and radial strata of the joint cartilage, proliferation of subchondral bone, and the development of osteophytes were noted. As for muscles, diameters of musclar fibers became smaller; in particular, type II fibers showed greater shrinkage. Regarding kidneys, swelling and atrophy of glomerular capillaries, proliferation of mesangial cells, nephroselerosis, swelling, thinning, and loss of tubular epithelium, interstitial tissue inflammation, development of cylindruria, and deposition of calcium were observed. All these changes seem to be a particularly advanced aspect of the changes which are more pronounced with increasing dose and age.These changes were found even in the group administered with the feed containing 0.1% phosphorus, and, these changes were dependent on the concentration level of P. It was observed that administration to older subjects for a short term (1.5 months) produced effects stronger than those to younger subjects administered for a long term (10.5 months).The effects of condensed Ca-phosphate on bones were similar to those of condensed Na- and K-phosphates, and, hence, it was supposed that these effects were caused by phosphate radicals.

Entities:  

Keywords:  1 α; 25 (OH)2D3; Acceptable daily intake; Bone; Condensed phosphate; Food additive; Kidney; Maximum non-effect level (MNL); Osteopolosis

Year:  1997        PMID: 21432463      PMCID: PMC2723539          DOI: 10.1007/BF02931975

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  10 in total

1.  [The hydrolysis and excretion of polymeric phosphate].

Authors:  R E GOSSELIN; A ROTHSTEIN; G J MILLER; H L BERKE
Journal:  J Pharmacol Exp Ther       Date:  1952-10       Impact factor: 4.030

2.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

3.  Hypocalcemia, hyperparathyroidism and bone resorption in rats induced by dietary phosphate.

Authors:  T L Sie; H H Draper; R R Bell
Journal:  J Nutr       Date:  1974-09       Impact factor: 4.798

4.  Effect of dietary phosphorus on calcium metabolism in intact and parathyroidectomized adult rats.

Authors:  G H Anderson; H H Draper
Journal:  J Nutr       Date:  1972-09       Impact factor: 4.798

5.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

6.  [Intake and urinary excretion of Ca and P by Japanese].

Authors:  K Hirata; H Kikuchi; T Ozawa; H Hanaoka; M Kondo; S Morimoto
Journal:  Nihon Rinsho       Date:  1982

7.  The relationship of Ca and P nutrition during adult life and osteoporosis in aged mice.

Authors:  B G Shah; G V Krishnarao; H H Draper
Journal:  J Nutr       Date:  1967-05       Impact factor: 4.798

Review 8.  Dietary phosphorus, calcium metabolism and bone.

Authors:  M S Calvo
Journal:  J Nutr       Date:  1993-09       Impact factor: 4.798

9.  Physiological responses of human adults to foods containing phosphate additives.

Authors:  R R Bell; H H Draper; D Y Tzeng; H K Shin; G R Schmidt
Journal:  J Nutr       Date:  1977-01       Impact factor: 4.798

10.  Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods.

Authors:  M S Calvo; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1988-04       Impact factor: 5.958

  10 in total
  2 in total

Review 1.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Bonekey Rep       Date:  2015-06-03

Review 2.  The deep-sea natural products, biogenic polyphosphate (Bio-PolyP) and biogenic silica (Bio-Silica), as biomimetic scaffolds for bone tissue engineering: fabrication of a morphogenetically-active polymer.

Authors:  Xiaohong Wang; Heinz C Schröder; Qingling Feng; Florian Draenert; Werner E G Müller
Journal:  Mar Drugs       Date:  2013-03-08       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.